Companies
- Companies
- Browse
Companies
Kalight is devoted to developing patents dealing with viral CNS conditions and seeking licensees and partnerships. Currently, it is marketing its patent for certain herpes neurological conditions. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Apr 2011 - 24 pages - $1,000
Aug 2009 - 180 pages - $3,500
Mar 2011 - 32 pages - $250
Jan 2010 - $75
Dec 2010 - 48 pages - $1,000
May 2009 - 131 pages - $3,800
Nov 2011 - 7 pages - $3,835
Jun 2006 - 1458 pages - $2,495
Nov 2011 - 168 pages - $3,835
Your selection
Browse By
- Therapeutic target
- Candida
- Cytomegalovirus
- Ebola virus
- Escherichia coli
- Haemophilus influenzae
- Hantavirus
- Helicobacter pylori
- Herpes simplex virus
- Human B19 parvovirus
- Human papilloma virus
- Parainfluenza virus (Type 3)
- Pertussis
- Respiratory syncytial virus RSV
- Rubella
- Salmonella
- Varicella-zoster
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us